CAR T-Cell Therapy: Applying the Data, Tailoring Treatment, and Future Considerations

In this online program based on a series of live webinars, experts discuss best practices and emerging strategies in CAR T-cell therapy for patients with leukemia, lymphoma, and myeloma. Download slides with all the key data, watch the on-demand Webcast, and listen to a podcast in which frequently asked questions are addressed.
Michael R. Bishop, MD
Program Director
Michael R. Bishop, MD
Daniel J. DeAngelo, MD, PhD
Noopur Raje, MD

On-Demand Video Webcast

In this interactive on-demand Webcast, an expert panel discusses how they currently use CAR T-cells to treat hematologic malignancies and provides a look ahead at new data and promising agents that may soon change practice.

Michael R. Bishop, MD
Program Director
Daniel J. DeAngelo, MD, PhD Noopur Raje, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits ABIM MOC: maximum of 1.5 Medical Knowledge MOC point(s) Released: August 14, 2020 Expired: August 13, 2021

Downloadable Slidesets

Download this short summary slideset of key takeaway points from a live presentation on CAR T-cell therapy for lymphomas, leukemias, and multiple myeloma.

Michael R. Bishop, MD Daniel J. DeAngelo, MD, PhD Noopur Raje, MD Released: June 30, 2020

Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with lymphomas and CLL.

Michael R. Bishop, MD Released: June 23, 2020

Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with ALL.

Daniel J. DeAngelo, MD, PhD Released: June 23, 2020

Download this slideset for expert perspectives on emerging strategies in the use of CAR T-cell therapy for patients with multiple myeloma.

Noopur Raje, MD Released: June 23, 2020

Download this slideset for expert perspectives on managing toxicities associated with CAR T-cell therapy.

Noopur Raje, MD Released: June 23, 2020

Podcast

Listen to Michael R. Bishop, MD; Daniel J. DeAngelo, MD, PhD; and Noopur Raje, MD, answer audience questions from a series of live CCO Webinars focused on current best practices and emerging applications with CAR T-cell therapy.

Michael R. Bishop, MD
Program Director
Daniel J. DeAngelo, MD, PhD Noopur Raje, MD
Released: September 14, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Celgene Corporation
Legend Biotech USA Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue